You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Hardened, Optically-Based Temperature Characterization of Detonation Environments
SBC: SA PHOTONICS, LLC Topic: DTRA19B001Improving the effectiveness of counter-WMD operations requires improved understanding of weapon-target interaction. Specifically, time-resolved measurements of temperature and composition are required to allow temporal evolution of a detonation fireball. To address this need, SA Photonics will develop MONITOR, a laser-based temperature diagnostic which will enable wide dynamic range temperature me ...
STTR Phase II 2022 Department of DefenseDefense Threat Reduction Agency -
Compact Laser Drivers for Photoconductive Semiconductor Switches- STTR Phase II Sequential
SBC: SCIENTIFIC APPLICATIONS & RESEARCH ASSOCIATES, INC. Topic: DTRA16A004For effective protection against radiated threats, produced by high altitude electromagnetic pulse (HEMP) caused by nuclear detonations and high-power microwave (HPM) Directed Energy (DE) weapons it is important to understand not only the physics of the threats, but also to quantify the effects on mission-critical electrical systems. EMP/HMP simulators enable threat level testing of MCS and provid ...
STTR Phase II 2022 Department of DefenseDefense Threat Reduction Agency -
CO2mposite: Recycling of CO2, Carbon Fiber Waste, and Biomaterials into Composite Panels for Lower Embodied Carbon Building Materials
SBC: SKYNANO LLC Topic: NA"SkyNano, Endeavor Composites, and The University of Tennessee Knoxville propose to develop a composite panel that contains CO2-derived carbon nanotubes (CNTs), recycled carbon fiber waste, and bio-derived natural fibers that exhibits excellent mechanical and functional properties, while maintaining a carbon-negative footprint on a cradle-to-gate and cradle-to-grave basis. By the end of the Phase ...
STTR Phase II 2022 Department of EnergyARPA-E -
CO2mposite: Recycling of CO2, Carbon Fiber Waste, and Biomaterials into Composite Panels for Lower Embodied Carbon Building Materials
SBC: SKYNANO LLC Topic: NA"SkyNano, Endeavor Composites, and The University of Tennessee Knoxville propose to develop a composite panel that contains CO2-derived carbon nanotubes (CNTs), recycled carbon fiber waste, and bio-derived natural fibers that exhibits excellent mechanical and functional properties, while maintaining a carbon-negative footprint on a cradle-to-gate and cradle-to-grave basis. By the end of the Phase ...
STTR Phase II 2022 Department of EnergyARPA-E -
Computer Vision Image Interpretation for 3D Model Reconstruction
SBC: TOYON RESEARCH CORPORATION Topic: DTRA18B001Toyon Research Corporation (Toyon) and the University of California, Santa Barbara (UCSB) propose research, development, and demonstration of algorithms and an efficient software prototype for 3D model reconstruction using single images collected via remote sensing. In particular, the effort is focused on processing of high-resolution commercial satellite images for 3D reconstruction of buildings. ...
STTR Phase II 2021 Department of DefenseDefense Threat Reduction Agency -
Marburg Virus Prophylactic Medical Countermeasure
SBC: Flow Pharma, Inc. Topic: CBD18A002Through this STTR contract, we propose to evaluate the efficacy of our vaccine, FlowVax Marburg, in nonhuman primates (NHPs). This will be achieved through four Tasks. In Task 1, we will manufacture the vaccine in a quantity sufficient for the animal studies. In Task 2, we will perform MHC genotyping on a representative population of NHPs and, based on results, select a set of MHC-matched NHPs for ...
STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense -
Marburg Virus Prophylactic Medical Countermeasure
SBC: MAPP BIOPHARMACEUTICAL, INC. Topic: CBD18A002There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terrible morbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditional vaccines have contributed greatly to public health, they have some limitations especially in the context of operati ...
STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense -
Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases
SBC: CFD RESEARCH CORPORATION Topic: CBD18A001In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens, whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial and alphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable an ...
STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense -
A Novel, Microscale, Distributable Sensor Technology for Ionizing Radiation
SBC: CFD RESEARCH CORPORATION Topic: DTRA14B004Terrorist use of radioactive nuclear materials via nuclear and/or radiological dispersion devices (dirty bombs) is a serious threat. Therefore, it is crucial to detect proliferation of nuclear material. Critical challenges include: (a) high sensitivity detection of signature emissions from radioactive isotopes, and (b) cost-effectiveness for deployment of sensor networks across large storage facil ...
STTR Phase II 2019 Department of DefenseDefense Threat Reduction Agency -
Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point ofCare Applications
SBC: GENECAPTURE, INC. Topic: CBD15C001GeneCapture, Inc. is proposing to develop a rapid in vitro diagnostic prototype using our patented molecular-based CAPTURE (ConfirmActive Pathogens Through Unamplified RNA Expression) assay. Based on the results and experience gained in our Phase I STTR contractHDTRA1-16C-0061: Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications, we p ...
STTR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense